Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802033 · ClinicalTrials.gov registry record
A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders
A clinical trial of Degenerative Diseases, Spinal Cord, sponsored by AO Innovation Translation Center.
- Active
- Registry status
- 908
- Enrollment target
- 7
- Study locations
NCT02802033: Active study of Degenerative Diseases, Spinal Cord, sponsored by AO Innovation Translation Center.
NCT02802033 is a study of Degenerative Diseases, Spinal Cord that is active but no longer recruiting, run by AO Innovation Translation Center. The registered enrollment target is 908 participants. The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02802033, a study of Degenerative Diseases, Spinal Cord, is active but no longer recruiting, sponsored by AO Innovation Translation Center.
- ACTIVE NOT RECRUITING
- Registry status
- 908 participants
- Enrollment target
- 7
- Study locations
Study Summary
Details regarding the degenerative spine disorders will be collected with a specific focus on the use of osteobiologics in treating degenerative conditions and their impact on fusion, as well as patient-reported outcomes for these conditions.
Primary Outcome
Osteobiologics are classified as autogenous bone graft substitutes, extenders, or enhancers. Types of osteobiologics include demineralized bone matrices (DBM), allografts and allograft formulations, synthetic bone grafts, bone morphogenic proteins, bone marrow aspirate systems, stem cells and platelet-rich plasma systems. The biologics are generally defined as being derived from or replicating natural substances. The osteobiologics are defined as such by possessing one or more of the following p
Conditions Studied
Study Locations (7)
New York
- Mount Sinai Hospital - New York
- New York Presbyterian - Columbia University Medical Center - New York
Other
- BG-Clinic Bergmannstrost - Halle
- Istituto Ortopedico Rizzoli - Bologna
California
- USC Spine Center, Keck Medical Center of USC - Los Angeles
Georgia
- Emory University School of Medicine - Atlanta
Maryland
- The Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 908 participants |
| Start Date | 2016-01 |
| Est. Completion | 2026-12 |
What the registry record for NCT02802033 still lists
NCT02802033 is an observational study that tracks outcomes without assigning an intervention. The registered 908 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Degenerative Diseases, Spinal Cord appearing as the primary indexed condition, and to 0 interventions.
NCT02802033 lists 7 locations in 5 states (New York, Other, California).
Frequently Asked Questions
What is clinical trial NCT02802033 about?
NCT02802033 is a clinical study titled "A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders". Details regarding the degenerative spine disorders will be collected with a specific focus on the use of osteobiologics in treating degenerative conditions and their impact on fusion, as well as patient-reported outcomes for these conditions.
What is the current status of trial NCT02802033?
This trial is currently active not recruiting. The enrollment target is 908 participants. The study started on 2016-01. Estimated completion is 2026-12.
What conditions does trial NCT02802033 study?
This clinical trial studies the following conditions: Degenerative Diseases, Spinal Cord.
Who is sponsoring clinical trial NCT02802033?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02802033 being conducted?
This trial has 7 study locations across California, Georgia, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia